Clinical Trials

Pfizer and BioNTech claim their two-dose COVID-19 mRNA vaccine (BNT162b2) is more than 90 percent effective.

Fujifilm Toyama's influenza treatment passes COVID-19 trial.

Most clinical trials against COVID-19 exclude the very patients most at risk from the disease.

Nominations are now open for The Medicine Maker 2021 Power List.

Can we trust the integrity of clinical trials?

AstraZeneca's George Kirk tells us the story of Koselugo – a treatment for the rare genetic condition neurofibromatosis 1.

From patient recruitment to distributing products, we ask how clinical trials can weather the COVID-19 pandemic.

When developing countermeasures against COVID-19, resource-poor settings should not be forgotten.

In what may have been one of the last advanced therapy meetings to go ahead for some time, delegates met in London in late February for CAR-TCR.

We catch up with a new CEO about his goals for a clinical trials business.